Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data-Reference-Cited by-同舟云学术

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data

Published:2019-07 Issue:7 Volume:6 Page:e359-e365
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Kushnir Margarita,Choi Yun,Eisenberg Ruth,Rao Devika,Tolu Seda,Gao Jackson,Mowrey Wenzhu,Billett Henny H

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

3. Dabigatran versus warfarin in the treatment of acute venous thromboembolism;Schulman;N Engl J Med,2009

4. Oral apixaban for the treatment of acute venous thromboembolism;Agnelli;N Engl J Med,2013

5. Oral rivaroxaban for symptomatic venous thromboembolism;Bauersachs;N Engl J Med,2010

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity and cardiovascular disease: an ESC clinical consensus statement;European Journal of Preventive Cardiology;2024-08-30

2. Obesity and cardiovascular disease: an ESC clinical consensus statement;European Heart Journal;2024-08-30

3. Anticoagulation and compression therapy for proximal acute deep vein thrombosis;Vasa;2024-07-17

4. Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-06-27

5. Safety and Efficacy of Direct Oral Anticoagulants vs Warfarin in Patients With Obesity and Venous Thromboembolism: A Retrospective Analysis;Texas Heart Institute Journal;2024-05-15